Green Biologics Overview
- Year Founded
-
2002
- Status
-
Out of Business
- Employees
-
14
- Latest Deal Type
-
Out of Business
Green Biologics General Information
Description
Operator of an industrial biotechnology platform designed to exploit the protein production capabilities of versatile microbes. The company's platform uses fermentation to produce renewable butanol from feedstocks including corn and cellulosic feedstocks, enabling pharmaceutical companies to access renewable butanol used in paints, coatings, adhesives, inks, plastics, pharmaceuticals, household cleaners, and personal care products.
Contact Information
Website
www.greenbiologics.comCorporate Office
- Thatched House High Street
- Wargrave, Reading
- Berkshire RG10 8JA
- England, United Kingdom
Corporate Office
- Thatched House High Street
- Wargrave, Reading
- Berkshire RG10 8JA
- England, United Kingdom
Green Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 26. Out of Business | 16-Dec-2025 | Completed | Out of Business | |||
| 25. Later Stage VC | 02-Mar-2022 | Completed | Generating Revenue | |||
| 24. Later Stage VC (Series 1) | 21-Dec-2020 | Completed | Generating Revenue | |||
| 23. Grant | 01-Oct-2020 | Completed | Generating Revenue | |||
| 22. IBO | 01-Jan-2019 | Completed | Generating Revenue | |||
| 21. Later Stage VC | 10-Oct-2018 | Completed | Generating Revenue | |||
| 20. Grant | 01-Jun-2018 | Completed | Generating Revenue | |||
| 19. Grant | 01-Apr-2018 | Completed | Generating Revenue | |||
| 18. Debt - General | 31-Dec-2017 | $15.8M | $175M | Completed | Generating Revenue | |
| 17. Grant | 01-Sep-2017 | $403K | $159M | Completed | Generating Revenue |
Green Biologics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| C1 Ordinary | ||||||||
| C1 Ordinary | ||||||||
| Ordinary | ||||||||
| B1 Ordinary | ||||||||
| B Ordinary | ||||||||
| Ordinary | 1,116,750 | $0.000131 | $2.57 | $2.57 | 1x | $2.57 | 0.63% | |
| B Ordinary | 9,224,676 | $0.000131 | $2.14 | $2.14 | 1x | $2.14 | 5.18% |
Green Biologics Comparisons
Industry
Financing
Details
Green Biologics Competitors (11)
One of Green Biologics’s 11 competitors is Arzeda, a Venture Capital-Backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arzeda | Venture Capital-Backed | Seattle, WA | ||||
| Novonesis | Corporation | Lyngby, Denmark | ||||
| Amyris (Biotechnology) | Private Equity-Backed | Emeryville, CA | ||||
| Molecular Cloning Laboratories | Corporation | South San Francisco, CA | ||||
| Barentzymes | Corporation | Haugesund, Norway |
Green Biologics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Green Biologics Patents
Green Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201716845-D0 | Process | Inactive | 13-Oct-2017 | ||
| GB-201816751-D0 | Process | Inactive | 13-Oct-2017 | ||
| GB-2569220-A | Process | Inactive | 13-Oct-2017 | ||
| US-11584914-B2 | Processes for producing organic solvents using clostridium saccharoperbutylacetonicum | Active | 13-Oct-2017 | ||
| EP-3694983-A1 | Processes involving clostridium saccharoperbutylacetonicum | Inactive | 13-Oct-2017 | C12N1/20 |
Green Biologics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Green Biologics Acquisitions (2)
Green Biologics’s most recent deal was a Merger/Acquisition with Central MN Renewables. The deal was made on 23-Dec-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Central MN Renewables | 23-Dec-2014 | Merger/Acquisition | Industrial Chemicals | ||
| Butylfuel | 20-Jan-2012 | Merger/Acquisition | Environmental Services (B2B) |
Green Biologics FAQs
-
When was Green Biologics founded?
Green Biologics was founded in 2002.
-
Where is Green Biologics headquartered?
Green Biologics is headquartered in Berkshire, United Kingdom.
-
What is the size of Green Biologics?
Green Biologics has 14 total employees.
-
What industry is Green Biologics in?
Green Biologics’s primary industry is Biotechnology.
-
Is Green Biologics a private or public company?
Green Biologics is a Private company.
-
What is Green Biologics’s current revenue?
The current revenue for Green Biologics is .
-
How much funding has Green Biologics raised over time?
Green Biologics has raised $2.69M.
-
Who are Green Biologics’s competitors?
Arzeda, Novonesis, Amyris (Biotechnology), Molecular Cloning Laboratories, and Barentzymes are some of the 11 competitors of Green Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
